永安药业(002365)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002365 永安药业

已收盘 03-25 15:00:00

{"stockData":{"symbol":"002365","market":"SZ","secType":"STK","nameCN":"永安药业","latestPrice":13.37,"timestamp":1774422228000,"preClose":13.33,"halted":0,"volume":4397300,"delay":0,"changeRate":0.003,"floatShares":246000000,"shares":295000000,"eps":0.0863,"marketStatus":"已收盘","change":0.04,"latestTime":"03-25 15:00:00","open":13.39,"high":13.45,"low":13.26,"amount":58792200,"amplitude":0.0143,"askPrice":13.38,"askSize":209,"bidPrice":13.37,"bidSize":19,"shortable":0,"etf":0,"ttmEps":0.0863,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774488600000},"marketStatusCode":5,"adr":0,"adjPreClose":13.33,"symbolType":"stock","openAndCloseTimeList":[[1774402200000,1774409400000],[1774414800000,1774422000000]],"highLimit":14.66,"lowLimit":12,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":294682500,"isCdr":false,"pbRate":1.99,"roa":"--","peRate":154.924681,"roe":"1.28%","epsLYR":0.2107,"committee":-0.608321,"marketValue":3940000000,"turnoverRate":0.0179,"status":0,"floatMarketCap":3283000000},"requestUrl":"/m/hq/s/002365","defaultTab":"news","newsList":[{"id":"2621082466","title":"股市必读：永安药业（002365）3月23日收盘跌5.82%，主力净流出48.24万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621082466","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621082466?lang=zh_cn&edition=full","pubTime":"2026-03-24 04:54","pubTimestamp":1774299251,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，永安药业报收于12.78元，下跌5.82%，换手率4.47%，成交量10.97万手，成交额1.43亿元。来自股本股东变化：截至3月10日股东户数环比下降1.81%，户均持股上升至6253.0股。交易信息汇总股价提醒3月23日永安药业收盘报12.78元，跌5.82%，当日成交1096.8万元。该股已连续5日下跌。前10个交易日主力资金累计净流出1164.93万元，股价累计下跌10.15%。股本股东变化股东户数变动截至2026年3月10日，公司股东户数为4.71万户，较2月27日减少868.0户，减幅1.81%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400005293.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002365","BK0239","BK0086","BK0028"],"gpt_icon":0},{"id":"2617527541","title":"股市必读：永安药业（002365）3月5日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2617527541","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617527541?lang=zh_cn&edition=full","pubTime":"2026-03-06 01:39","pubTimestamp":1772732350,"startTime":"0","endTime":"0","summary":"截至2026年3月5日收盘，永安药业报收于14.15元，上涨1.51%，换手率2.28%，成交量5.6万手，成交额7925.73万元。董秘最新回复投资者： 请问贵公司与杭州新城路是否有业务合作？截止2026年2月27日，公司股东人数为47,996户。当日关注点来自交易信息汇总：3月5日主力资金净流出338.97万元，散户资金净流入398.57万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030600000853.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","002365","BK0086"],"gpt_icon":0},{"id":"2617207514","title":"永安药业：公司与上述主体无业务合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2617207514","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617207514?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:30","pubTimestamp":1772699432,"startTime":"0","endTime":"0","summary":"证券之星消息，永安药业(002365)03月05日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司与杭州新城路是否有业务合作？永安药业回复：感谢您的关注！公司与上述主体无业务合作。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030500025947.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002365","BK0028","BK0086","BK0239"],"gpt_icon":0},{"id":"2616357490","title":"股市必读：永安药业(002365)股东户数4.83万户，较上期减少0.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616357490","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616357490?lang=zh_cn&edition=full","pubTime":"2026-03-03 01:52","pubTimestamp":1772473933,"startTime":"0","endTime":"0","summary":"截至2026年3月2日收盘，永安药业报收于14.35元，下跌3.82%，换手率3.89%，成交量9.56万手，成交额1.38亿元。股本股东变化股东户数变动近日永安药业披露，截至2026年2月13日公司股东户数为4.83万户，较2月10日减少424.0户，减幅为0.87%。本次增资完成后，永安康健注册资本将由11,000万元增至16,000万元，公司仍持有其100%股权。减持后合计持有公司股份805,900股，占公司总股本比例0.2735%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300001038.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0028","002365","BK0239"],"gpt_icon":0},{"id":"2616829308","title":"永安药业最新公告：参股公司黄冈日化被其全资子公司吸收合并完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2616829308","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616829308?lang=zh_cn&edition=full","pubTime":"2026-03-01 17:10","pubTimestamp":1772356221,"startTime":"0","endTime":"0","summary":"永安药业(002365.SZ)公告称，参股公司黄冈日化已完成被其全资子公司天安日化吸收合并的相关事宜。合并后，黄冈日化将予以注销，其全部资产、负债、权益由天安日化依法承继。公司原对黄冈日化的3,000万元投资将转变为对天安日化的投资，持股比例仍为6.5217%。此次吸收合并不涉及现金收付，且不会对公司的财务状况产生实际性影响。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100006549.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002365","BK0239","BK0086","BK0028"],"gpt_icon":0},{"id":"2613278799","title":"永安药业(002365)2月10日股东户数4.87万户，较上期减少1.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613278799","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613278799?lang=zh_cn&edition=full","pubTime":"2026-02-24 17:21","pubTimestamp":1771924903,"startTime":"0","endTime":"0","summary":"证券之星消息，近日永安药业披露，截至2026年2月10日公司股东户数为4.87万户，较1月30日减少548.0户，减幅为1.11%。在化学制药行业个股中，永安药业股东户数高于行业平均水平，截至2月10日，化学制药行业平均股东户数为3.43万户。从股价来看，2026年1月30日至2026年2月10日，永安药业区间涨幅为1.21%，在此期间股东户数减少548.0户，减幅为1.11%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400032377.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002365","BK0086","BK0239"],"gpt_icon":0},{"id":"2610074667","title":"股市必读：永安药业(002365)股东户数4.92万户，较上期减少1.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610074667","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610074667?lang=zh_cn&edition=full","pubTime":"2026-02-10 08:08","pubTimestamp":1770682087,"startTime":"0","endTime":"0","summary":"h2,h3,h4{padding: 10px 0;font-size: 16px;line-height: 30px;color:#262626;font-weight: 600;}h2{border-bottom: 1px solid #d8dee4; padding-bottom: 0.3em}.article_content ul{padding-left:22px;}截至2026年2月9日收盘，永安药业报收于15.03元，下跌0.07%，换手率2.47%，成交量6.07万手，成交额9108.42万元。来自股本股东变化：截至2026年1月30日，公司股东户数环比下降1.29%，户均持股上升至5986.0股，表明筹码集中度有所提升。股东户数变动近日永安药业披露，截至2026年1月30日公司股东户数为4.92万户，较1月20日减少643.0户，减幅为1.29%。户均持股数量由上期的5909.0股增加至5986.0股，户均持股市值为8.88万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260210/32008816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","BK0028","BK0086","002365"],"gpt_icon":0},{"id":"2610633098","title":"永安药业(002365)1月30日股东户数4.92万户，较上期减少1.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610633098","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610633098?lang=zh_cn&edition=full","pubTime":"2026-02-09 17:27","pubTimestamp":1770629245,"startTime":"0","endTime":"0","summary":"证券之星消息，近日永安药业披露，截至2026年1月30日公司股东户数为4.92万户，较1月20日减少643.0户，减幅为1.29%。在化学制药行业个股中，永安药业股东户数高于行业平均水平，截至1月30日，化学制药行业平均股东户数为3.43万户。从股价来看，2026年1月20日至2026年1月30日，永安药业区间跌幅为6.55%，在此期间股东户数减少643.0户，减幅为1.29%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020900022170.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0086","BK0028","002365"],"gpt_icon":0},{"id":"2607039609","title":"永安药业（002365）披露2025年度业绩预告，1月29日股价下跌0.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607039609","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607039609?lang=zh_cn&edition=full","pubTime":"2026-01-29 23:14","pubTimestamp":1769699655,"startTime":"0","endTime":"0","summary":"截至2026年1月29日收盘，永安药业报收于14.98元，较前一交易日下跌0.93%，最新总市值为44.14亿元。该股当日开盘15.1元，最高15.25元，最低14.85元，成交额达1.16亿元，换手率为3.13%。近日，潜江永安药业股份有限公司发布2025年度业绩预告，预计归属于上市公司股东的净利润为1,818.59万元至2,704.79万元，比上年同期下降56.21%至70.56%；扣除非经常性损益后的净利润为-288.22万元至-155.20万元，同比下降105.80%至110.77%。业绩下滑主要因牛磺酸市场低迷，产品产销量及销售价格同比下降。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900044357.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0086","002365"],"gpt_icon":0},{"id":"2606268001","title":"股市必读：永安药业（002365）1月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2606268001","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606268001?lang=zh_cn&edition=full","pubTime":"2026-01-26 01:33","pubTimestamp":1769362391,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，永安药业报收于16.12元，上涨2.09%，换手率5.93%，成交量14.55万手，成交额2.34亿元。截止2026年1月20日，公司股东人数为49,873户。来自公司公告汇总：永安药业召开2026年第一次临时股东会，审议通过吸收合并全资子公司湖北凌安科技有限公司的议案。出席股东共472人，代表股份77,785,386股，占公司有表决权股份总数的26.9018%。两项议案均获得有效表决权股份总数的三分之二以上通过，表决结果合法有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600000670.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002365","BK0086","BK0239","BK0028"],"gpt_icon":0},{"id":"2605497475","title":"永安药业（002365）披露吸收合并全资子公司议案获股东会通过，1月22日股价上涨0.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605497475","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605497475?lang=zh_cn&edition=full","pubTime":"2026-01-22 22:33","pubTimestamp":1769092396,"startTime":"0","endTime":"0","summary":"截至2026年1月22日收盘，永安药业报收于15.79元，较前一交易日上涨0.7%，最新总市值为46.53亿元。该股当日开盘15.69元，最高15.85元，最低15.53元，成交额达1.34亿元，换手率为3.47%。出席股东共472人，代表股份77,785,386股，占公司有表决权股份总数的26.9018%。两项议案均获得有效表决权股份总数的三分之二以上通过，表决结果合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200041049.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0086","BK0239","002365"],"gpt_icon":0},{"id":"2604154446","title":"永安药业：截止2026年1月9日股东人数为50,786户","url":"https://stock-news.laohu8.com/highlight/detail?id=2604154446","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604154446?lang=zh_cn&edition=full","pubTime":"2026-01-20 09:01","pubTimestamp":1768870864,"startTime":"0","endTime":"0","summary":"证券之星消息，永安药业(002365)01月19日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，您好！请问公司截至1月10日的股东人数是多少？永安药业回复：感谢您的关注！截止2026年1月9日，公司股东人数为50,786户。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000005614.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0028","002365","BK0239"],"gpt_icon":0},{"id":"2603616429","title":"永安药业：1月13日高管李少波减持股份合计2000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2603616429","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603616429?lang=zh_cn&edition=full","pubTime":"2026-01-14 21:01","pubTimestamp":1768395694,"startTime":"0","endTime":"0","summary":"证券之星消息，根据1月14日市场公开信息、上市公司公告及交易所披露数据整理，永安药业（002365）最新董监高及相关人员股份变动情况：2026年1月13日公司高管李少波共减持公司股份2000.0股，占公司总股本为0.0007%。变动期间公司股价下跌0.13%，1月13日当日收盘报15.74元。永安药业近半年内的董监高及核心技术人员增减持详情如下：永安药业的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400039582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0028","002365","BK0239"],"gpt_icon":0},{"id":"2602437951","title":"永安药业：1月8日高管李少波减持股份合计5000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2602437951","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602437951?lang=zh_cn&edition=full","pubTime":"2026-01-09 21:35","pubTimestamp":1767965741,"startTime":"0","endTime":"0","summary":"证券之星消息，根据1月9日市场公开信息、上市公司公告及交易所披露数据整理，永安药业（002365）最新董监高及相关人员股份变动情况：2026年1月8日公司高管李少波共减持公司股份5000.0股，占公司总股本为0.0017%。变动期间公司股价上涨1.16%，1月8日当日收盘报15.76元。永安药业近半年内的董监高及核心技术人员增减持详情如下：永安药业的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900039630.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002365","BK0239","BK0028","BK0086"],"gpt_icon":0},{"id":"2601338603","title":"永安药业：截至2025年12月31日股东人数为49,527户","url":"https://stock-news.laohu8.com/highlight/detail?id=2601338603","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601338603?lang=zh_cn&edition=full","pubTime":"2026-01-08 08:57","pubTimestamp":1767833827,"startTime":"0","endTime":"0","summary":"证券之星消息，永安药业(002365)01月07日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，您好！请问公司截至12月31日的股东人数是多少？谢谢永安药业回复：感谢您的关注！截止2025年12月31日，公司股东人数为49,527户。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800006240.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0239","BK0028","002365"],"gpt_icon":0},{"id":"2601860437","title":"永安药业最新公告：拟吸收合并全资子公司凌安科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2601860437","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601860437?lang=zh_cn&edition=full","pubTime":"2026-01-06 17:00","pubTimestamp":1767690053,"startTime":"0","endTime":"0","summary":"永安药业公告称，为优化管理架构，提高运营效率，降低管理成本，公司拟吸收合并全资子公司凌安科技，合并完成后凌安科技将注销，其资产、债权、债务等由公司承继。此次吸收合并不构成关联交易或重大资产重组，需提交股东会审议。凌安科技最近一年及一期的财务数据显示，其资产总额和负债总额均有所下降，净利润为负。吸收合并完成后，公司存续经营，注册资本、名称、股本结构及董事会、高级管理人员等将保持不变。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600027704.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002365","BK0086","BK0239","BK0028"],"gpt_icon":0},{"id":"2601029729","title":"股市必读：永安药业（002365）12月31日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2601029729","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601029729?lang=zh_cn&edition=full","pubTime":"2026-01-05 02:54","pubTimestamp":1767552851,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，永安药业报收于14.92元，下跌0.8%，换手率2.15%，成交量5.28万手，成交额7917.24万元。董秘最新回复投资者： 公司牛磺酸是否满产？公司主营产品牛磺酸实行以销定产的生产模式，目前正在按照生产计划有序开展生产经营活动，具体请查阅公司年度定期报告。当日关注点来自交易信息汇总：12月31日主力资金净流出1264.63万元，占总成交额15.97%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500000894.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0239","BK0028","002365"],"gpt_icon":0},{"id":"2595722406","title":"永安药业：牛磺酸实行以销定产","url":"https://stock-news.laohu8.com/highlight/detail?id=2595722406","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595722406?lang=zh_cn&edition=full","pubTime":"2025-12-31 16:45","pubTimestamp":1767170714,"startTime":"0","endTime":"0","summary":"证券之星消息，永安药业(002365)12月31日在投资者关系平台上答复投资者关心的问题。投资者提问：公司牛磺酸是否满产？永安药业回复：感谢您的关注！公司主营产品牛磺酸实行以销定产的生产模式，目前正在按照生产计划有序开展生产经营活动，具体请查阅公司年度定期报告。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100028989.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002365","BK0239","BK0086","BK0028"],"gpt_icon":0},{"id":"2591698259","title":"永安药业：12月15日高管洪仁贵、方锡权、熊盛捷减持股份合计4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2591698259","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591698259?lang=zh_cn&edition=full","pubTime":"2025-12-16 21:01","pubTimestamp":1765890108,"startTime":"0","endTime":"0","summary":"证券之星消息，根据12月16日市场公开信息、上市公司公告及交易所披露数据整理，永安药业（002365）最新董监高及相关人员股份变动情况：2025年12月15日公司董事,高管洪仁贵、高管方锡权、董秘,高管熊盛捷共减持公司股份4.0万股，占公司总股本为0.0136%。变动期间公司股价上涨0.07%，12月15日当日收盘报15.23元。永安药业近半年内的董监高及核心技术人员增减持详情如下：永安药业的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600038480.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0086","BK0239","002365"],"gpt_icon":0},{"id":"2589232353","title":"永安药业：12月5日高管熊盛捷减持股份合计10000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2589232353","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589232353?lang=zh_cn&edition=full","pubTime":"2025-12-08 21:02","pubTimestamp":1765198931,"startTime":"0","endTime":"0","summary":"证券之星消息，根据12月8日市场公开信息、上市公司公告及交易所披露数据整理，永安药业（002365）最新董监高及相关人员股份变动情况：2025年12月5日公司董秘,高管熊盛捷共减持公司股份1.0万股，占公司总股本为0.0034%。变动期间公司股价上涨0.25%，12月5日当日收盘报15.73元。永安药业近半年内的董监高及核心技术人员增减持详情如下：永安药业的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120800032116.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","002365","BK0239","BK0028"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1774432702940,"stockEarnings":[{"period":"1week","weight":-0.0678},{"period":"1month","weight":-0.0749},{"period":"3month","weight":-0.119},{"period":"6month","weight":-0.2352},{"period":"1year","weight":0.6252},{"period":"ytd","weight":-0.1066}],"compareEarnings":[{"period":"1week","weight":-0.0416},{"period":"1month","weight":-0.0492},{"period":"3month","weight":-0.0151},{"period":"6month","weight":0.0073},{"period":"1year","weight":0.1517},{"period":"ytd","weight":-0.0221}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"潜江永安药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"47128人(较上一季度减少1.81%)","perCapita":"5210股","listingDate":"2010-03-05","address":"湖北省潜江市经济开发区广泽大道2号","registeredCapital":"29468万元","survey":"　　潜江永安药业股份有限公司的主营业务是牛磺酸产品、保健食品、特殊膳食食品（肌酸）的研发、生产和销售。公司的主要产品是牛磺酸产品、保健食品、特殊膳食食品（肌酸）。","listedPrice":31},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"永安药业(002365)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供永安药业(002365)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"永安药业,002365,永安药业股票,永安药业股票老虎,永安药业股票老虎国际,永安药业行情,永安药业股票行情,永安药业股价,永安药业股市,永安药业股票价格,永安药业股票交易,永安药业股票购买,永安药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"永安药业(002365)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供永安药业(002365)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}